Zoetis Inc (ZTS) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $72.32 (-0.96%), Market cap $33.09B, P/E ratio 12.94, 52-week low–high $74.22 ~ $170.30.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care di
Financial statements, price targets, institutional (13F) holdings and related news for Zoetis Inc are updated in real time on BlackAll Trade.
Zoetis Inc trades at $72.32 (-0.96%). Real-time quotes and charts are available on BlackAll Trade.
Zoetis Inc has a market cap of about $33.09B. Its P/E ratio is 12.94.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health s